Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for RBSH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 -0.129M
September 30, 2022 -0.131M
June 30, 2022 -0.322M
March 31, 2022 -0.124M
December 31, 2021 -0.284M
September 30, 2021 -0.135M
June 30, 2021 -0.128M
March 31, 2021 -0.146M
December 31, 2020 -0.129M
September 30, 2020 -0.083M
June 30, 2020 -0.035M
March 31, 2020 -0.127M
December 31, 2019 -0.027M
September 30, 2019 -0.179M
June 30, 2019 -0.047M
March 31, 2019 -0.06M
December 31, 2018 -0.043M
September 30, 2018 -0.155M
June 30, 2018 -0.003M
March 31, 2018 -0.003M
December 31, 2017 -0.008M
September 30, 2017 -0.261M
June 30, 2017 -0.117M
Date Value
March 31, 2017 -0.709M
December 31, 2016 -0.598M
September 30, 2016 -0.60M
June 30, 2016 -0.632M
March 31, 2016 -0.907M
December 31, 2015 -1.013M
September 30, 2015 -1.142M
June 30, 2015 -1.282M
March 31, 2015 -1.20M
December 31, 2014 -1.243M
September 30, 2014 -1.232M
June 30, 2014 -1.562M
March 31, 2014 -1.011M
December 31, 2013 -1.278M
September 30, 2013 -1.28M
June 30, 2013 -1.146M
March 31, 2013 -1.011M
December 31, 2012 -1.054M
September 30, 2012 -1.461M
June 30, 2012 -0.9687M
March 31, 2012 -1.044M
December 31, 2011 -1.124M
September 30, 2011 -1.260M
June 30, 2011 -1.027M
March 31, 2011 -0.3337M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 95.69M
Alnylam Pharmaceuticals, Inc. 292.04M
Anika Therapeutics, Inc. -2.133M
Savara, Inc. -29.97M
Vericel Corp. 14.26M